首页> 外文期刊>VideoGIE >Placing a lumen-apposing metal stent despite ascites: feasibility and safety
【24h】

Placing a lumen-apposing metal stent despite ascites: feasibility and safety

机译:尽管腹水放置一个腔吸金属支架:可行性和安全性

获取原文
           

摘要

Background and AimsPlacing a lumen-apposing metal stent (LAMS) through ascites carries serious risks, including death from leakage around the LAMS and failure to create a mature fistula between the 2 lumens. However, sometimes no options exist or are equally dangerous. We present 5 patients who underwent LAMS placement despite ascites in 2 different locations.MethodsThis is a retrospective review of 5 patients who underwent LAMS placement despite ascites in 2 different locations from 2016 to?2018.ResultsThree patients with cholecystitis and 2 patients with afferent limb syndrome and severe ascites were treated with a combination of preprocedural and intraprocedural paracentesis. Serum ascites albumin gradient was measured. Weight was recorded daily. Patients were encouraged to sleep at an incline, and periodic paracentesis (every 3-7 days) was performed when ascites reaccumulated over 4 weeks. Median volume of ascites aspirated was 2 L preprocedurally and 300 mL intraprocedurally. Only 1 patient had ascites with a high serum ascites albumin gradient and was treated with diuretics. Technical and clinical success was achieved in all 5 patients without any adverse events over a median follow-up of 28 weeks.ConclusionsIn situations in which no better options remain, LAMS placement appears to be safe after adequate and aggressive treatment of the underlying ascites pre-, intra-, and postprocedurally. Larger studies are needed to establish the safety of this approach.
机译:背景和Aimsplating通过腹水(LAM)通过腹水带来严重的风险,包括脉冲周围的泄漏死亡,并且未能在2流明之间产生成熟的瘘管。但是,有时没有任何选择或同样危险。我们展示了5名患有林下的患者,尽管2种不同的地点。虽然是2016年的2个不同地点的腹水腹膜腹肌腹膜腹部腹膜腹部,但是,我们仍然有5名患者的患者。虽然是河流的5名患者,但是2018年的2个不同地点。胆囊炎患者和胆囊炎的2例患者并用预活化和颅腺间腹向的组合治疗严重的腹水。测量血清腹水白蛋白梯度。每天记录重量。鼓励患者在倾斜度下睡眠,当腹水重新升温4周内时,会定期腹腔气囊(每3-7天)。吸入的腹水中位数是2L预先预浸和300ml内部。只有1例患者腹水具有高血清腹水白蛋白梯度,并用利尿剂处理。在28周的中位随访中没有任何不良事件的所有5名患者中取得了技术和临床成功。在没有更好的选择仍然存在的情况下,林下似乎在潜在腹水的充分和激进治疗后似乎安全似乎是安全的,内,和后期。需要更大的研究来建立这种方法的安全性。

著录项

  • 来源
    《VideoGIE》 |2020年第11期|共5页
  • 作者

    Shayan Irani;

  • 作者单位
  • 收录信息
  • 原文格式 PDF
  • 正文语种
  • 中图分类
  • 关键词

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号